Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 372–372 | Cite as

Nivolumab

Immune oesophagitis: case report
Case report
  • 23 Downloads

Reference

  1. Lesueur P, et al. Safety of combined PD-1 pathway inhibition and radiation therapy for non-small-cell lung cancer: A multicentric retrospective study from the GFPC. Cancer Medicine 7: 5505-5513, No. 11, Nov 2018. Available from: URL: http://doi.org/10.1002/cam4.1825 - FranceCrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations